Cargando…

Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study

BACKGROUND: Exacerbation of chronic obstructive pulmonary disease (ECOPD) is a complex phenomenon, with marked heterogeneity in the aetiology, pathophysiology and clinical manifestations. This study aimed to evaluate the clinical characteristics and long-term outcomes of patients with 30-day exacerb...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ye, He, Ruoxi, Dong, Fen, Liu, Dongyan, Ren, Xiaoxia, Yang, Ting, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462968/
https://www.ncbi.nlm.nih.gov/pubmed/37640511
http://dx.doi.org/10.1136/bmjresp-2023-001759
_version_ 1785098148904960000
author Wang, Ye
He, Ruoxi
Dong, Fen
Liu, Dongyan
Ren, Xiaoxia
Yang, Ting
Wang, Chen
author_facet Wang, Ye
He, Ruoxi
Dong, Fen
Liu, Dongyan
Ren, Xiaoxia
Yang, Ting
Wang, Chen
author_sort Wang, Ye
collection PubMed
description BACKGROUND: Exacerbation of chronic obstructive pulmonary disease (ECOPD) is a complex phenomenon, with marked heterogeneity in the aetiology, pathophysiology and clinical manifestations. This study aimed to evaluate the clinical characteristics and long-term outcomes of patients with 30-day exacerbation among those hospitalised with ECOPD in China. METHODS: Data from the Acute Exacerbations of Chronic Obstructive Pulmonary Disease Inpatient Registry were used in this study. The patients were divided into re-event and non-event groups based on the incidence of re-exacerbation within 30 days of discharge. Exacerbation, severe exacerbation and all-cause readmissions in the following 12 months were the outcomes of interest. The cumulative incidence rates and incidence densities were calculated. Multivariate hazard function models were used to determine the association between 30-day re-exacerbation and the long-term outcomes after accounting for the competing risk of death. RESULTS: Re-exacerbation within 30 days of discharge was observed in 4.9% (n=242) of the patients (n=4963). The cumulative incidence rates and incidence densities of exacerbation, severe exacerbation and all-cause readmissions in the event group were significantly higher than those in the non-event group. After adjustment, re-exacerbation within 30 days of discharge was associated with increased risks of exacerbation, severe exacerbation and all-cause readmissions in the following 12 months (adjusted HR: 3.85 (95% CI: 3.09 to 4.80), 3.46 (2.66 to 4.50) and 3.28 (2.52 to 4.25) accordingly). CONCLUSION: Re-exacerbation of COPD within 30 days of discharge is a significant predictor of long-term prognosis. In clinical practice, short-term re-exacerbation is a significant clinical phenotype of ECOPD that requires careful management at the earliest.
format Online
Article
Text
id pubmed-10462968
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104629682023-08-30 Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study Wang, Ye He, Ruoxi Dong, Fen Liu, Dongyan Ren, Xiaoxia Yang, Ting Wang, Chen BMJ Open Respir Res Chronic Obstructive Pulmonary Disease BACKGROUND: Exacerbation of chronic obstructive pulmonary disease (ECOPD) is a complex phenomenon, with marked heterogeneity in the aetiology, pathophysiology and clinical manifestations. This study aimed to evaluate the clinical characteristics and long-term outcomes of patients with 30-day exacerbation among those hospitalised with ECOPD in China. METHODS: Data from the Acute Exacerbations of Chronic Obstructive Pulmonary Disease Inpatient Registry were used in this study. The patients were divided into re-event and non-event groups based on the incidence of re-exacerbation within 30 days of discharge. Exacerbation, severe exacerbation and all-cause readmissions in the following 12 months were the outcomes of interest. The cumulative incidence rates and incidence densities were calculated. Multivariate hazard function models were used to determine the association between 30-day re-exacerbation and the long-term outcomes after accounting for the competing risk of death. RESULTS: Re-exacerbation within 30 days of discharge was observed in 4.9% (n=242) of the patients (n=4963). The cumulative incidence rates and incidence densities of exacerbation, severe exacerbation and all-cause readmissions in the event group were significantly higher than those in the non-event group. After adjustment, re-exacerbation within 30 days of discharge was associated with increased risks of exacerbation, severe exacerbation and all-cause readmissions in the following 12 months (adjusted HR: 3.85 (95% CI: 3.09 to 4.80), 3.46 (2.66 to 4.50) and 3.28 (2.52 to 4.25) accordingly). CONCLUSION: Re-exacerbation of COPD within 30 days of discharge is a significant predictor of long-term prognosis. In clinical practice, short-term re-exacerbation is a significant clinical phenotype of ECOPD that requires careful management at the earliest. BMJ Publishing Group 2023-08-28 /pmc/articles/PMC10462968/ /pubmed/37640511 http://dx.doi.org/10.1136/bmjresp-2023-001759 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Chronic Obstructive Pulmonary Disease
Wang, Ye
He, Ruoxi
Dong, Fen
Liu, Dongyan
Ren, Xiaoxia
Yang, Ting
Wang, Chen
Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
title Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
title_full Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
title_fullStr Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
title_full_unstemmed Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
title_short Re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
title_sort re-exacerbation within 30 days of discharge is associated with poor prognosis in the following year among patients hospitalised with exacerbation of chronic obstructive pulmonary disease: a clinical cohort study
topic Chronic Obstructive Pulmonary Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462968/
https://www.ncbi.nlm.nih.gov/pubmed/37640511
http://dx.doi.org/10.1136/bmjresp-2023-001759
work_keys_str_mv AT wangye reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy
AT heruoxi reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy
AT dongfen reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy
AT liudongyan reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy
AT renxiaoxia reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy
AT yangting reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy
AT wangchen reexacerbationwithin30daysofdischargeisassociatedwithpoorprognosisinthefollowingyearamongpatientshospitalisedwithexacerbationofchronicobstructivepulmonarydiseaseaclinicalcohortstudy